
    
      Explore the efficacy and safety of the treatment of Endostar continuous intravenous injection
      pump combined GP（gemcitabine+cisplatin） scheme for first-line advanced non small cell lung
      cancer and maintenance treatment.

      main objectives: PFS (progression-free survival) the secondary goal: ORR (overall response
      rate), DCR (disease control rate) and OS（overall survival）
    
  